LICENSE AGREEMENTLicense Agreement • November 6th, 2019 • Nanoviricides, Inc. • Services-commercial physical & biological research • New York
This LICENSE AGREEMENT (“Agreement”) is made and entered into as of the 1st day of November, 2019 (the “Agreement Date”) by and between TheraCour Pharma, Inc., a Connecticut corporation (“Licensor”) and NanoViricides, Inc., a Nevada corporation (“Licensee”). Licensor and Licensee are each referred to herein individually, as a “Party” and collectively, as the “Parties.”
